Al Ittihad Drug Store and Ahmad Tabari

branded drugs: Generics have only about a 5-6 per cent market share in the GCC, with patented drugs dominating the landscape, according to a report from Alpen Capital published in 2013, according to Business Week. That means that firms have to work hard to convert patients from branded drugs over to a generic. Incentives for manufacturers, including fast track approval, is helping supply Late next year the UAE-based pharmaceutical distributor Al Ittihad Drug Store will leap up the value chain when it opens Pharmax, a $20 million facility to manufacture generic pharmaceuticals in DuBiotech . By targeting the chronic illness sector with medicines to treat ailments including hypertension, diabetes and depression, the firm hopes to win over customers and then keep them for life, says its group CEO, Ahmad Tabari. Tabari says that whether the medicine will be used for a short period, like an antibiotic, or to treat a long-term illness, the effort is roughly the same. That our view. The bang for your buck is much better in the chronic medication sector. (news.financializer.com). As reported in the news.